Plenary Sessions-23/04/2021

Friday, April 23rd, 2021

15:00 - 15:30

Plenary Lecture: 6th Simon Karpatkin Memorial Lecture

Chairs: A. Falanga (Italy); B. Brenner (Israel); A.A. Khorana (USA)

Introduction to Lecture
F.R. Rickles (USA)

Risk prediction for cancer-associated thrombosis in ambulatory patients with cancer - past, present and future
I. Pabinger (Austria)

15:30 - 17:00

Plenary session 1: New Insights In Prevalence of Cancer-Associated Thrombosis

Chairs: H.A. Liebman (USA), M. Aapro (Switzerland)

PL-01 - Screening for Occult Cancer: Where Are We in 2020?
L. Jara-Palomares (Spain)

PL-02 - An overview of thrombotic complications of old and new anti-cancer drugs
M. Levi (The Netherlands)

PL-03 - Impact of arterial thrombosis in cancer patients
S.C. Cannegieter (The Netherlands)

PL-04 - Cancer associated thrombosis in pediatric setting
G. Kenet (Israel)

Selected Abstract

OC-04 - Incidence, Predictors and Clinical Outcomes of Venous Thromboembolism in Patients with Newly Diagnosed Pancreatic Ductal Adenocarcinoma: Results of the Prospective BACAP-VTE Study
C. Frere, B. Bournet, S. Gourgou, J. Fraisse, C. Canivet, J.M. Connors, L. Buscail, D. Farge, on behalf of the Groupe Francophone Thrombose et Cancer and the BACAP Consortium. (France, Canada, USA)

OC-05 - Risk of venous thromboembolism in cancer patients: a cohort study
F. Mulder, E. Horváth-Puhó, 
N. van Es, H.W.M. van Laarhoven, L. Pedersen, H.R. Büller, H.T. Sørensen  (The Netherlands, Denmark)

17:00 - 17:30

Roundtable: Risk assessment models for VTE in cancer

Chairs: P. Angchaisuksiri (Thailand), C. Ay (Austria)

Introduction: Overview of risk assessment models for VTE in ambulatory patients with cancer
G. Gerotziafas (France)

Discussant: N. Van Es (The Netherlands), A. Falanga (Italy), A.A. Khorana (USA), G. Gerotziafas (France), M.B. Donati (Italy)